Materials • Major Chemicals
$11.12 ▲ +0.83
(+8.07%)
MKT CAP: $800.6M • VOL: 1.60M
52W L $8 52W H $17
ROARABLE / RQD
C+ • 68/100
PIOTROSKI
8 / 9
LXU // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $615.2M | $522.4M | $593.7M |
| YoY Revenue Growth % | +17.8% | -12.0% | — |
| Gross Profit | $104.3M | $47.8M | — |
| Gross Margin % | 17.0% | 9.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $57.3M | -$5.5M | $51.8M |
| Operating Margin % | 9.3% | -1.1% | 8.7% |
| Net Income (GAAP) | $24.6M | -$19.4M | $27.9M |
| EBITDA (Normalized) | $119.2M | $68.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $95.5M | $86.6M | $137.5M |
| Capital Expenditures (CapEx) | $77.5M | $92.3M | — |
| Free Cash Flow (FCF) | $18.1M | -$5.7M | $137.5M |
| FCF Margin % | 2.9% | -1.1% | 23.2% |
| Return on Invested Capital (ROIC %) | 4.8% | -0.5% | — |
| Cash & Short-Term Equivalents | $19.5M | $20.2M | — |
| Total Debt (Short + Long Term) | $440.3M | $476.2M | — |
| Total Stockholders' Equity | $520.0M | $491.6M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR LXU.